当前位置： SCI文献检索 > VACCINE期刊下所有文献 > Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

Abstract：

:It has been known that influenza A virus infection induces a cross-protective immunity against infection by viruses with different subtypes of viral envelope proteins, hemagglutinin (HA) and neuraminidase (NA). This heterosubtypic immunity is generally mediated by cytotoxic T lymphocytes (CTL) reactive to specific epitopes in the viral internal proteins, such as nucleoprotein and matrix protein. By contrast, immunization with inactivated virus antigens has been thought to be unable to generate heterosubtypic immunity, since inactivated antigens do not usually induce CTL responses. However, we show that intranasal immunization with formalin-inactivated intact virus, but not ether-split vaccines, induced a broad spectrum of heterosubtypic protective immunity in mice. The protection may be mediated by the mucosal immune response, most likely secretory IgA antibodies to the viral proteins. This approach may overcome limitations in the efficacy of inactivated influenza vaccines and confer potent immunity to humans against viruses with new pandemic potential.

journal_name

Vaccine

journal_title

Vaccine

authors

Takada A,Matsushita S,Ninomiya A,Kawaoka Y,Kida H

doi

10.1016/s0264-410x(03)00234-2

subject

Has Abstract

pub_date

2003-07-04 00:00:00

pages

3212-8

issue

23

eissn

0264-410X

issn

1873-2518

pii

S0264410X03002342

journal_volume

21

pub_type

杂志文章

相关文献

VACCINE文献大全

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.
abstract：:An effective virus-like particle (VLP) based prophylactic vaccine designed to protect against persistent infection with human papillomavirus (HPV) types 16 and 18 and subsequent lesion development will need to induce a strong humoral and cellular immune response capable of providing long-term protection. Our objective...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2006.06.005

authors： Giannini SL,Hanon E,Moris P,Van Mechelen M,Morel S,Dessy F,Fourneau MA,Colau B,Suzich J,Losonksy G,Martin MT,Dubin G,Wettendorff MA

更新日期：2006-08-14 00:00:00
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
abstract：:A recombinant Plasmodium falciparum circumsporozoite (CS) antigen (rPfCSA) was produced in insect cells using a baculovirus expression vector containing the entire CS gene. This near full-length CS antigen was adsorbed onto aluminium phosphate for use as a malaria vaccine. In a study of safety and immunogenicity, 20 v...

journal_title：Vaccine

pub_type： 临床试验,杂志文章

doi：10.1016/0264-410x(92)90047-n

authors： Herrington DA,Losonsky GA,Smith G,Volvovitz F,Cochran M,Jackson K,Hoffman SL,Gordon DM,Levine MM,Edelman R

更新日期：1992-01-01 00:00:00
Willingness to participate in Ebola viral disease vaccine trials and receive vaccination by health workers in a tertiary hospital in Ile-Ife, Southwest Nigeria.
abstract：BACKGROUND:Ebola viral disease (EVD) epidemic need to be contained through means which include vaccination of susceptible population. Vaccination has eradicated major killer diseases. OBJECTIVE:The study determined the health workers willingness to participate in EVD vaccine clinical trials and receive EVD vaccine. M...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2016.10.004

authors： Olowookere SA,Abioye-Kuteyi EA,Adekanle O

更新日期：2016-11-11 00:00:00
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.
abstract：BACKGROUND:Development of influenza vaccines that do not use embryonated eggs as the substrate for vaccine production is a high priority. We conducted this study to determine the protective efficacy a recombinant, baculovirus-expressed seasonal trivalent influenza virus hemagglutinin (rHA0) vaccine (FluBlok(®)). METHO...

journal_title：Vaccine

pub_type： 杂志文章,多中心研究,随机对照试验

doi：10.1016/j.vaccine.2011.07.128

authors： Treanor JJ,El Sahly H,King J,Graham I,Izikson R,Kohberger R,Patriarca P,Cox M

更新日期：2011-10-13 00:00:00
Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: a nationwide interview survey.
abstract：:We assessed adult male and female awareness and acceptance of human papillomavirus (HPV) infection and vaccination for cervical cancer prevention, as well as factors associated with willingness to be administered the HPV vaccine. A nationwide population-based interview survey was conducted in Korea. One thousand male ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2009.11.079

authors： Oh JK,Lim MK,Yun EH,Lee EH,Shin HR

更新日期：2010-02-17 00:00:00
Efficacy of a divalent and a multivalent water-in-oil formulated vaccine against a highly virulent strain of Flavobacterium psychrophilum after intramuscular challenge of rainbow trout (Oncorhynchus mykiss).
abstract：:Flavobacterium psychrophilum is a well-known pathogen causing significant problems in aquaculture worldwide. In recent years an increasing number of disease outbreaks caused by F. psychrophilum has been reported on juvenile and post smolts of rainbow trout (Oncorhynchus mykiss) in Norway. The current study was perform...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2013.01.016

authors： Fredriksen BN,Olsen RH,Furevik A,Souhoka RA,Gauthier D,Brudeseth B

更新日期：2013-04-08 00:00:00
Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
abstract：:A dengue virus vaccine candidate, rDEN4Delta30, has been previously reported to be safe and immunogenic in humans, but a subset of vaccinees developed asymptomatic rash, elevation of liver enzymes and/or mild neutropenia. In the current study, mutations that had previously been shown to reduce replication of DEN4 viru...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2004.02.031

authors： Hanley KA,Manlucu LR,Manipon GG,Hanson CT,Whitehead SS,Murphy BR,Blaney JE Jr

更新日期：2004-09-03 00:00:00
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.
abstract：:A large, randomized, placebo-controlled clinical trial in Italy on two three-component pertussis vaccines, given as DTaP in infancy, one manufactured by SmithKline and Beecham (SB) and one by Chiron Biocine (CB), found each vaccine to be 84% efficacious through the average age of 24 months. The cohort of children enro...

journal_title：Vaccine

pub_type： 临床试验,杂志文章,随机对照试验

doi：10.1016/s0264-410x(98)00040-1

authors： Salmaso S,Mastrantonio P,Wassilak SG,Giuliano M,Anemona A,Giammanco A,Tozzi AE,Ciofi degli Atti ML,Greco D

更新日期：1998-08-01 00:00:00
Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen.
abstract：:This study demonstrates that liposomes administered to the lower respiratory tract of mice have the capacity to stimulate secretory IgA (s-IgA) antibody production in the female urogenital system. Total respiratory tract immunization of mice with influenza virus subunit antigen simply mixed with negatively charged lip...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/0264-410x(94)00062-r

authors： de Haan A,Renegar KB,Small PA Jr,Wilschut J

更新日期：1995-05-01 00:00:00
Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial.
abstract：BACKGROUND:Combination antiretroviral therapy (cART) is the main therapeutic management tool for HIV/AIDS. Despite its success in controlling viral load and disease progression, cART is expensive, associated with a range of significant side effects and depends for its efficacy on the patient's life-long commitment to h...

journal_title：Vaccine

pub_type： 杂志文章,多中心研究,随机对照试验

doi：10.1016/j.vaccine.2013.09.057

authors： Boffito M,Fox J,Bowman C,Fisher M,Orkin C,Wilkins E,Jackson A,Pleguezuelos O,Robinson S,Stoloff GA,Caparrós-Wanderley W

更新日期：2013-11-19 00:00:00
Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.
abstract：BACKGROUND:Since the introduction of mumps-containing vaccines (MuCV) in 1995 in Beijing, two-dose MuCV vaccination policy has been used, with the 1st and 2nd doses given at 18 months and 6 years of age, respectively. METHODS:Mumps epidemiology during 2005-2016 was described using surveillance data. Vaccine effectiven...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2018.03.074

authors： Ma R,Lu L,Zhou T,Pan J,Chen M,Pang X

更新日期：2018-05-03 00:00:00
Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children
abstract：INTRODUCTION:Ghana introduced monovalent rotavirus vaccine in April 2012. We sought to determine the long-term impact of routine rotavirus vaccination on rotavirus gastroenteritis hospitalizations in Ghana during the first 4 years following rotavirus vaccine introduction. METHODS:Active sentinel surveillance for acute...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2018.02.058

authors： Enweronu-Laryea CC,Armah G,Sagoe KW,Ansong D,Addo-Yobo E,Diamenu SK,Mwenda JM,Parashar UD,Tate JE

更新日期：2018-11-12 00:00:00
Has the public lost confidence in vaccines because of a vaccine scandal in China.
abstract：BACKGROUND:A vaccine manufacturer in China and regulatory authorities have been the focus of widespread outrage due to a vaccine scandal. We conducted a rapid survey during a time of intense mainstream and social media attention to determine whether the public's confidence in vaccines was affected. METHODS:We selected...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2019.07.052

authors： Han B,Wang S,Wan Y,Liu J,Zhao T,Cui J,Zhuang H,Cui F

更新日期：2019-08-23 00:00:00
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.
abstract：:We show here that the immunogenicity of the Modified Vaccinia Ankara MVA vaccine strain can be improved by deletion of the A35 gene, without diminishing the ability of the virus to replicate. Deletion of the A35 gene resulted in increased virus-specific immunoglobulin production, class switching to IgG isotypes, and v...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2011.02.023

authors： Rehm KE,Roper RL

更新日期：2011-04-12 00:00:00
Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs.
abstract：:Seneca Valley virus (SVV) infection in pigs is associated with porcine idiopathic vesicular disease (PIVD). Outbreaks of SVV infection in pig herds have been reported in several Asia and Americas countries. Recently, a series of outbreaks of SVV infection occurred in China, Canada, Thailand and the United States. Howe...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2017.12.055

authors： Yang F,Zhu Z,Cao W,Liu H,Zhang K,Tian H,Liu X,Zheng H

更新日期：2018-02-01 00:00:00
A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
abstract：:Universal infant vaccination with the 7-valent pneumococcal conjugate vaccine (PCV7) has nearly eliminated PCV7-serotype invasive pneumococcal disease (IPD) in young U.S. children, but has been accompanied by increases in the incidence of serotype 19A IPD. Because antibiotic-non-susceptible 19A has increased more than...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2010.03.030

authors： Van Effelterre T,Moore MR,Fierens F,Whitney CG,White L,Pelton SI,Hausdorff WP

更新日期：2010-05-07 00:00:00
Zika virus knowledge, attitudes, and vaccine interest among university students.
abstract：BACKGROUND:Zika virus vaccine development is underway. We examined interest in receiving a Zika virus vaccine (after one becomes commercially available) among students at a large public university in Northern Virginia. METHODS:An online survey of Zika virus-related knowledge, attitudes, and interest in receiving a Zik...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2016.12.050

authors： Painter JE,Plaster AN,Tjersland DH,Jacobsen KH

更新日期：2017-02-07 00:00:00
The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis.
abstract：:The replication of simian immunodeficiency virus (SIV) in acutely infected CD4+ cells can be inhibited in vitro by CD8-suppressor factors (SF) and beta-chemokines induced by immunization of macaques with SIV gp120 and p27 in Alum. A comparison between intradermal, naso-rectal-i.m. and targeted iliac lymph node (TILN) ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(98)00482-4

authors： Wang Y,Tao L,Mitchell E,Bergmeier L,Doyle C,Lehner T

更新日期：1999-04-09 00:00:00
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
abstract：:ADVAX is a DNA-based candidate HIV vaccine that was safe but weakly immunogenic when delivered intramuscularly (IM) in humans. Studies were performed in animal models to determine whether an alternative delivery method, in vivo electroporation (EP), could improve the immunogenicity of ADVAX while maintaining an accept...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2010.11.011

authors： Dolter KE,Evans CF,Ellefsen B,Song J,Boente-Carrera M,Vittorino R,Rosenberg TJ,Hannaman D,Vasan S

更新日期：2011-01-17 00:00:00
Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals.
abstract：:Integration of health services brings together common functions within and between organizations to solve common problems, developing a commitment to a shared vision and goals, and using common technologies and resources to achieve these goals. Integration has been the frustrated rally call of Primary Health Care for ...

journal_title：Vaccine

pub_type： 杂志文章,评审

doi：10.1016/j.vaccine.2008.02.032

authors： Clements CJ,Nshimirimanda D,Gasasira A

更新日期：2008-04-07 00:00:00
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.
abstract：:We performed a randomized, controlled clinical trial to characterize the evolution of the adverse events associated with the fifth consecutive dose of an acellular pertussis vaccine, and to assess the level of discomfort associated with the injection and the attitude of parents concerning these events. A total of 505 ...

journal_title：Vaccine

pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

doi：10.1016/s0264-410x(03)00173-7

authors： Halperin SA,Scheifele D,Mills E,Guasparini R,Humphreys G,Barreto L,Smith B

更新日期：2003-06-02 00:00:00
Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease.
abstract：:Although rare, invasive meningococcal disease remains an important cause of mortality and morbidity in children and young adults. Vaccines have been successfully introduced to help protect against meningococcal disease caused by serogroups A, C, W and Y, but until recently, a vaccine for serogroup B (MenB) was not ava...

journal_title：Vaccine

pub_type： 杂志文章,评审

doi：10.1016/j.vaccine.2015.11.057

authors： Watson PS,Turner DP

更新日期：2016-02-10 00:00:00
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine.
abstract：:FHbp is a major serogroup B meningococcal vaccine antigen. Binding of complement Factor H (FH) to FHbp is specific for human and some non-human primate FH. In previous studies, FH binding to FHbp vaccines impaired protective anti-FHbp antibody responses. In this study we investigated anti-FHbp antibody responses to a ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2015.10.135

authors： Giuntini S,Beernink PT,Granoff DM

更新日期：2015-12-16 00:00:00
Schistosoma japonicum calcium-binding tegumental protein SjTP22.4 immunization confers praziquantel schistosomulumicide and antifecundity effect in mice.
abstract：:A family of platyhelminth tegument-specific proteins comprising of one or two calcium ion binding EF-hand and a dynein light chain-like domain, termed tegumental proteins, are considered as candidates of vaccine. In this study, we cloned and characterized SjTP22.4, a novel membrane-anchored tegumental protein in Schis...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2012.05.056

authors： Zhang Z,Xu H,Gan W,Zeng S,Hu X

更新日期：2012-07-20 00:00:00
Evaluation of potentially achievable vaccination coverage with simultaneous administration of vaccines among children in the United States.
abstract：BACKGROUND:Routine administration of all age-appropriate doses of vaccines during the same visit is recommended for children by the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP). METHODS:Evaluate the potentially achievable vaccination coverage for ≥4 doses of di...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2016.04.097

authors： Zhao Z,Smith PJ,Hill HA

更新日期：2016-06-08 00:00:00
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
abstract：:Intranasal (i.n.) immunization of BALB/c mice with chimeric murine rotavirus EDIM (epizootic diarrhea of infant mice) VP6 and attenuated E. coli heat-labile toxin (LT), LT(R192G), stimulated >99% protection against rotavirus shedding after EDIM challenge. Here, we evaluated other potential adjuvants with chimeric VP6 ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(02)00043-9

authors： Choi AH,McNeal MM,Flint JA,Basu M,Lycke NY,Clements JD,Bean JA,Davis HL,McCluskie MJ,VanCott JL,Ward RL

更新日期：2002-03-15 00:00:00
Attitudes towards vaccination against seasonal influenza of health-care workers in primary health-care settings in Greece.
abstract：:Vaccination of health-care workers (HCWs) against seasonal influenza has been consistently recommended worldwide in order to prevent nosocomial transmission and ensure delivery of health-care services during outbreaks. We describe the effects of a nationwide campaign to promote influenza vaccination among HCWs working...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2010.06.108

authors： Dedoukou X,Nikolopoulos G,Maragos A,Giannoulidou S,Maltezou HC

更新日期：2010-08-23 00:00:00
Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine.
abstract：:We previously developed a dengue tetravalent DNA vaccine that can induce neutralizing antibodies against four dengue viruses in mice. Here, we demonstrated that immunogenicity of our tetravalent vaccine is synergistically increased in mice by co-immunization with dengue type 2 virus (DENV2) subviral extracellular part...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2006.09.059

authors： Imoto J,Konishi E

更新日期：2007-01-22 00:00:00
Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.
abstract：BACKGROUND:The burden of influenza is increasingly recognised in Africa. The WHO recommends introducing influenza vaccination to high-risk groups: pregnant women, children <5 years, and the elderly. The Gambia currently has no influenza vaccination policy, but the NASIMMUNE study, a clinical trial of intranasal live at...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2018.02.037

authors： Armitage EP,Camara J,Bah S,Forster AS,Clarke E,Kampmann B,de Silva TI

更新日期：2018-03-20 00:00:00
Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs).
abstract：:Using immunopotentiating, reconstituted influenza virosomes (IRIV) as a delivery vehicle, a number of vaccines have been developed. In humans, IRIV-based vaccines containing hepatitis A and influenza antigens have been found to possess enhanced immunogenicity compared to alum-adsorbed vaccine for hepatitis A or commer...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(98)00440-x

authors： Glück R

更新日期：1999-03-26 00:00:00